Nutraceuticals in cardio-metabolic therapy

22 

COD: NF-016-1033-2 Categoria:

DOI 10.17470/NF-016-1033-2

Giuseppe Derosa, Pamela Maffioli
Cardiovascular diseases are the leading cause of death in the Western world and the leading cause of death, hospitalization and disability among people with type 2 diabetes mellitus. The aim of this paper is to discuss which nutraceuticals could be helpful in controlling factors contributing to high cardiovascular risk, such as type 2 diabetes, hypertension and dyslipidaemia.


Nutraceuticals in cardio-metabolic therapy